Lv32
270 积分 2024-04-24 加入
Differential response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study
2小时前
待确认
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
4小时前
已完结
Dermatomyositis
4个月前
已完结
Dermatomyositis: Diagnosis and treatment
4个月前
已完结
Dermatomyositis: Clinical features and pathogenesis
4个月前
已完结
Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular Myasthenia Gravis
6个月前
已完结
Telitacicept: First Approval
1年前
已完结
皖公网安备34019202002308
